Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HMGN1 Protein | 1 | 2018 | 3 | 0.630 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 1696 | 0.620 |
Why?
|
| Trisomy | 1 | 2018 | 102 | 0.590 |
Why?
|
| Down Syndrome | 1 | 2018 | 198 | 0.510 |
Why?
|
| Re-Epithelialization | 1 | 2014 | 10 | 0.460 |
Why?
|
| Wilms Tumor | 1 | 2015 | 113 | 0.460 |
Why?
|
| Lipocalins | 1 | 2014 | 30 | 0.450 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 47 | 0.450 |
Why?
|
| Keratinocytes | 1 | 2014 | 63 | 0.450 |
Why?
|
| Repressor Proteins | 2 | 2015 | 816 | 0.440 |
Why?
|
| Genetic Markers | 1 | 2015 | 604 | 0.440 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 136 | 0.430 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 222 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 378 | 0.380 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 660 | 0.370 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 432 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2024 | 197 | 0.360 |
Why?
|
| Skin | 1 | 2014 | 517 | 0.360 |
Why?
|
| Cell Movement | 1 | 2014 | 835 | 0.350 |
Why?
|
| Lentivirus | 1 | 2011 | 82 | 0.350 |
Why?
|
| Wound Healing | 1 | 2014 | 436 | 0.350 |
Why?
|
| Genetic Techniques | 1 | 2011 | 106 | 0.350 |
Why?
|
| RNA Interference | 2 | 2011 | 498 | 0.340 |
Why?
|
| Cyclin E | 1 | 2009 | 30 | 0.330 |
Why?
|
| S Phase | 1 | 2009 | 73 | 0.320 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 2497 | 0.320 |
Why?
|
| G1 Phase | 1 | 2009 | 67 | 0.320 |
Why?
|
| Spliceosomes | 2 | 2021 | 53 | 0.300 |
Why?
|
| Genetic Vectors | 1 | 2011 | 939 | 0.270 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2522 | 0.270 |
Why?
|
| Genes, myc | 3 | 2018 | 100 | 0.250 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 418 | 0.240 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2021 | 235 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3152 | 0.240 |
Why?
|
| Ribonucleotides | 1 | 2024 | 36 | 0.230 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 3332 | 0.220 |
Why?
|
| RNA Stability | 1 | 2024 | 84 | 0.220 |
Why?
|
| Mutation | 3 | 2015 | 5818 | 0.210 |
Why?
|
| Transcription Factor RelA | 1 | 2021 | 53 | 0.180 |
Why?
|
| Supratentorial Neoplasms | 1 | 2021 | 36 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 30 | 0.180 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2020 | 35 | 0.180 |
Why?
|
| Cell Line | 2 | 2018 | 2748 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 189 | 0.160 |
Why?
|
| Ependymoma | 1 | 2021 | 125 | 0.160 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2020 | 88 | 0.160 |
Why?
|
| Nucleosomes | 1 | 2018 | 39 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 529 | 0.150 |
Why?
|
| Animals | 11 | 2024 | 34050 | 0.150 |
Why?
|
| Acetylation | 1 | 2018 | 166 | 0.150 |
Why?
|
| Mice | 9 | 2024 | 17629 | 0.150 |
Why?
|
| Lysine | 1 | 2018 | 194 | 0.150 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 55 | 0.150 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 413 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2015 | 616 | 0.140 |
Why?
|
| Genome | 1 | 2018 | 469 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2018 | 862 | 0.130 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 532 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2018 | 759 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2015 | 883 | 0.120 |
Why?
|
| RNA | 1 | 2018 | 570 | 0.120 |
Why?
|
| Histones | 1 | 2018 | 526 | 0.120 |
Why?
|
| Lipocalin-2 | 1 | 2014 | 29 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 1892 | 0.110 |
Why?
|
| Gene Amplification | 3 | 2021 | 228 | 0.110 |
Why?
|
| Spindle Apparatus | 2 | 2011 | 63 | 0.100 |
Why?
|
| beta Catenin | 1 | 2014 | 204 | 0.100 |
Why?
|
| Sirolimus | 1 | 2014 | 223 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 256 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2018 | 520 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 259 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 2045 | 0.100 |
Why?
|
| Mitosis | 2 | 2011 | 235 | 0.100 |
Why?
|
| Transcriptome | 1 | 2018 | 950 | 0.100 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 23 | 0.100 |
Why?
|
| Luminescence | 1 | 2011 | 15 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2011 | 19 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2582 | 0.090 |
Why?
|
| Gene Expression | 2 | 2014 | 1560 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2011 | 461 | 0.080 |
Why?
|
| Cell Nucleus Shape | 1 | 2009 | 2 | 0.080 |
Why?
|
| Nuclear Envelope | 1 | 2009 | 17 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4402 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 82 | 0.080 |
Why?
|
| ran GTP-Binding Protein | 1 | 2009 | 28 | 0.080 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2009 | 37 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2021 | 4504 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 60 | 0.080 |
Why?
|
| Humans | 12 | 2024 | 124297 | 0.080 |
Why?
|
| Schizosaccharomyces | 1 | 2009 | 66 | 0.080 |
Why?
|
| Phenotype | 1 | 2018 | 4251 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 276 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3268 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2015 | 707 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2009 | 217 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 464 | 0.070 |
Why?
|
| Mammary Glands, Animal | 1 | 2011 | 481 | 0.070 |
Why?
|
| Introns | 2 | 2021 | 299 | 0.070 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 663 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2021 | 227 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 555 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2014 | 3727 | 0.060 |
Why?
|
| Female | 9 | 2024 | 66330 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 353 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2861 | 0.060 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 63 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 1265 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 89 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 290 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 1002 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 167 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1068 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 294 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 1321 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 62 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 49 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 67 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 1295 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 552 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 100 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1328 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1782 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 222 | 0.030 |
Why?
|
| Doxycycline | 1 | 2014 | 117 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 170 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 806 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 206 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 402 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 354 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 806 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2014 | 363 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 336 | 0.030 |
Why?
|
| Estradiol | 1 | 2014 | 535 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 428 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 485 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 332 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 35 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 252 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 546 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 371 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 797 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1615 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 641 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4346 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 247 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 716 | 0.020 |
Why?
|
| ATP-Dependent Proteases | 1 | 2009 | 10 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2009 | 33 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 282 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 63 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 608 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 310 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2815 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 356 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 303 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 177 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 229 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 276 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 766 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1701 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 836 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6279 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12289 | 0.010 |
Why?
|
| Male | 1 | 2020 | 61050 | 0.010 |
Why?
|